Celsius (CELH) 10-Q 9 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 09, 2019
Document And Entity Information
Entity Registrant Name	Celsius Holdings, Inc.
Entity Central Index Key	0001341766
Document Type	10-Q
Trading Symbol	CELH
Document Period End Date	Mar. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity's Reporting Status Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		57,307,853
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash	$ 2,762,813	$ 7,743,181
Accounts receivable-net	12,154,448	12,980,396
Note receivable-current	1,224,529
Unbilled royalty revenue	89,587
Inventories, net	13,556,512	11,482,701
Prepaid expenses and other current assets	2,832,174	2,299,375
Total current assets	32,620,063	34,505,653
Note receivable-long term	11,020,766
Operating lease-right of use asset	223,991
Property and equipment-net	103,093	121,854
Total Assets	43,967,913	34,627,507
Current liabilities:
Accounts payable and accrued expenses	9,027,059	14,845,211
Other current liabilities	65,395	19,933
Operating Lease Liability-current	139,042
Total current liabilities	9,231,496	14,865,144
Long-term liabilities:
Line of credit note payable-related party-net	4,850,839	3,500,000
Convertible note payables -related party-net	4,527,815	4,459,381
Operating Lease Liability-Long Term	87,592
Total Liabilities	18,697,742	22,824,525
Stockholders' Equity:
Common stock, $0.001 par value; 75,000,000 shares authorized, 57,198,365 and 57,002,508 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively	57,198	57,003
Additional paid-in capital	86,703,402	85,153,667
Accumulated other comprehensive Income/(Loss)	233,668	(26,997)
Accumulated deficit	(61,724,097)	(73,380,691)
Total Stockholders' Equity	25,270,171	11,802,982
Total Liabilities and Stockholders' Equity	$ 43,967,913	$ 34,627,507

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	75,000,000	75,000,000
Common stock, issued	57,198,365	57,002,508
Common stock, outstanding	57,198,365	57,002,508

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Revenue	$ 14,485,650	$ 12,059,976
Cost of revenue	8,764,592	7,296,295
Gross profit	5,721,058	4,763,681
Selling and marketing expenses	3,601,003	5,599,271
General and administrative expenses	2,622,102	2,002,655
Total operating expense	6,223,105	7,601,926
Loss from operations	(502,047)	(2,838,245)
Other Income (Expense):
Interest income/(expense)-net	(28,632)	(38,259)
Amortization of Discount on Notes Payable	(85,940)
Gain on Investment repayment from China	12,273,213
Total Other Income/(Expense)	12,158,641	(38,259)
Net Income/(Loss)	11,656,594	(2,876,504)
Preferred stock dividend		(82,691)
Net Income/(Loss) available to common stockholders	$ 11,656,594	$ (2,959,195)
Income/(Loss) per share:
Basic	$ 0.2	$ (0.06)
Diluted	$ 0.19	$ (0.06)
Weighted average shares outstanding:
Basic	57,155,445	47,449,553
Diluted	61,687,409	47,449,553

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
Net Loss available to common stockholders, as reported	$ 11,656,594	$ (2,959,195)
Other comprehensive income (loss):
Unrealized foreign currency translation income (loss)	260,665	(53,504)
Comprehensive income	$ 11,917,259	$ (3,012,699)

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balances at beginning at Dec. 31, 2017	$ 7	$ 45,702	$ 79,101,824	$ (39,378)	$ (61,960,910)	$ 17,147,245
Balances at beginning (in shares) at Dec. 31, 2017	6,760	45,701,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in exchange of preferred stock	$ (4)	$ 4,651	(5,251)			(604)
Issuance of common stock in exchange of preferred stock (in shares)	(4,000)	4,651,163
Stock option expense			770,862			770,862
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 306	(306)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		306,340
Issuance of common stock pursuant to exercise of stock options - Cash		$ 298	142,329			142,627
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		297,773
Preferred stock dividend payable					(82,691)	(82,691)
Foreign currency translation income (loss)				(53,504)		(53,504)
Net income (loss)					(2,876,504)	(2,876,504)
Balances at ending at Mar. 31, 2018	$ 3	$ 50,957	80,009,458	(92,882)	(64,920,105)	15,047,431
Balances at ending (in shares) at Mar. 31, 2018	2,760	50,956,869
Balances at beginning at Dec. 31, 2018	$ 0	$ 57,003	85,153,667	(26,997)	(73,380,691)	11,802,982
Balances at beginning (in shares) at Dec. 31, 2018	0	57,002,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option expense			1,358,503			1,358,503
Issuance of common stock pursuant to exercise of stock options - Cashless		$ 115	(115)
Issuance of common stock pursuant to exercise of stock options - Cashless (in shares)		115,107
Issuance of common stock pursuant to exercise of stock options - Cash		$ 80	24,680			24,760
Issuance of common stock pursuant to exercise of stock options - Cash (in shares)		80,750
Beneficial Conversion Feature on Convertible Instruments			166,667			166,667
Preferred stock dividend payable
Foreign currency translation income (loss)				260,665		260,665
Net income (loss)					11,656,594	11,656,594
Balances at ending at Mar. 31, 2019	$ 0	$ 57,198	$ 86,703,402	$ 233,668	$ (61,724,097)	$ 25,270,171
Balances at ending (in shares) at Mar. 31, 2019	0	57,198,365

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net Income (loss)	$ 11,656,594	$ (2,876,504)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	107,343	7,953
Stock-based compensation expense	1,358,503	770,862
Gain on Investment repayment from China	(12,273,213)
Changes in operating assets and liabilities:
Accounts receivable, net	(2,488,198)	(2,698,222)
Inventories net	(2,332,499)	(1,363,237)
Prepaid expenses and other current assets	(707,984)	(1,977,614)
Accounts payable and accrued expenses	(2,070,134)	3,908,101
Accrued preferred dividends		(51,111)
Unbilled royalty revenue	(89,587)
Deposits/deferred revenue and other current liabilities	45,463	4,059
Net cash used in operating activities	(6,793,712)	(4,275,713)
Cash flows from investing activities:
Purchase of property and equipment		(11,717)
Net cash (used in) investing activities		(11,717)
Cash flows from financing activities:
Proceeds from notes payable related party-net	1,500,000
Proceeds from exercise of stock options	24,760	142,023
Net cash provided by financing activities	1,524,760	142,023
Effect on exchange rate changes on cash and cash equivalents	288,584	(53,504)
Net (decrease) increase in cash	(4,980,368)	(4,198,911)
Cash at beginning of the period	7,743,181	14,186,624
Cash at end of the period	2,762,813	9,987,713
Cash paid during period for:
Interest	28,632	38,259
Non-cash investing and financing activities:
Accrued preferred dividends		82,691
Non-Cash Items Related to China Settlement:
Accounts Receivable	3,314,146
Inventory	258,688
Pre-paid expense and other current assets	175,185
Accounts payable and accrued expenses	$ 3,748,019

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	1. ORGANIZATION AND DESCRIPTION OF BUSINESS Business Company Celsius Holdings The Company is engaged in the development, marketing, sale and distribution of “ functional

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation – US GAAP Commission Significant Estimates Segment Reporting Disclosed About Segments of an Enterprise and Related Information.) Our chief operating decision-maker is considered to be our Chief Executive Officer (CEO). The CEO reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying consolidated statement of operations. Therefore, the Company has determined that it operates in a single operating segment. For the three months ended March 31, 2019 and 2018 all material assets and revenues of the Company where in the United States except as disclosed in Note 2. Concentrations of Risk The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At March 31, 2019, the Company had approximately $2.5 million in excess of the Federal Deposit Insurance Corporation limit. For the three months ended March 31, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 17.9 % 18.0 % B* 0.1 % 11.6 % All other 82.0 % 70.4 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in China. Revenues from all other customers were mainly derived in the United States. At March 31, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 41.1 % 41.5 % All other 58.9 % 58.5 % Total 100.0 % 100.0 % *Receivables from customer A are derived from a customer located in Sweden. Cash Equivalents Accounts Receivable Inventories Property and Equipment Impairment of Long-Lived Assets Revenue Recognition Revenue is derived from the sale of beverages. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, slotting fees, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue. Customer Advances Advertising Costs Research and Development Foreign Currency Translation-Chinese Yuan Renminbi — As of and for the three months ended March 31, 2019 and March 31, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: March 31, 2019 March 31, 2018 Exchange rate on balance sheet dates USD : CNY exchange rate 6.71 6.29 Average exchange rate for the period USD : CNY exchange rate 6.75 6.36 Fair Value of Financial Instruments Fair Value Measurements Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. Other than these noted previously, the Company did not have any other assets or liabilities measured at fair value at March 31, 2019 and December 31, 2018. Income Taxes — Accounting for Uncertain Income Tax Positions. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25 Definition of Settlement, Earnings per Share There were no other dilutive common shares equivalents, including convertible notes and warrants, as no common share equivalents had an exercise price below the ending closing price of the year. The effects of dilutive instruments have not been presented as the effects would be anti-dilutive. Share-Based Payments Cost of Sales Operating Expenses Shipping and Handling Costs Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. In June 2016, the FASB issued ASU No. 2016-13 & updated in Nov 2018 ASU 2018-19, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. ASU 2016-13 is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2019. Early adoption is permitted after fiscal years beginning December 15, 2018. The Company is currently evaluating the potential impact of adopting this guidance on our financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820. The ASU is effective for the Registrants for fiscal years beginning after December 15, 2019, and interim periods therein. Early adoption is permitted. The Company is currently assessing the impact of this standard on their Financial Statements. All new accounting pronouncements issued but not yet effective are not expected to have a material impact on our results of operations, cash flows or financial position with the exception of the updated previously disclosed above, there have been no new accounting pronouncements not yet effective that have significance to our consolidated financial statements. Liquidity In addition to cash flow from operations, our primary sources of working capital have been private placements of our securities and our credit facilities with CD Financial, LLC (“CD Financial”), an affiliate of Carl DeSantis, a principal shareholder of the Company, as well as Charmnew Limited and Grieg International Limited. Charmnew Limited is an existing shareholder of record affiliated with Li Ka Shing, one of our principal shareholders. Grieg International Limited is an existing shareholder of record affiliated with Chau Hoi Shuen Solina, one of our principal shareholders. If our sales volumes do not meet our projections, expenses exceed our expectations, our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing.

REVENUE

REVENUE	3 Months Ended
	Mar. 31, 2019
Revenue from Contract with Customer [Abstract]
REVENUE	3. REVENUE The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Sales taxes and other similar taxes are excluded from revenue. Information about the Company’s net sales by reporting segment for the three months ended March 31, 2019 and 2018 are as follows: For the three months ended March 31, March 31, 2019 2018 North America $ 11,397,862 $ 8,096,080 Europe 2,999,664 2,506,433 Asia 52,764 1,389,277 Other 35,360 68,186 Net sales $ 14,485,650 $ 12,059,976 License Agreement In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement. Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation. The Company recognizes revenue from the agreement over time because the customer simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because its efforts in providing the exclusive license rights and ongoing support occur on a generally even basis throughout the year. Total revenue recognized under the agreement was approximately $90,000 for the three months ended March 31, 2019 and is reflected in the Company’s Asia reporting segment which was determined by the minimum royalties due during first year, as per the licensing agreement.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
INVENTORIES	4. INVENTORIES Inventories consist of the following at: March 31, December 31, 2019 2018 Finished goods $ 10,775,168 $ 8,739,877 Raw Materials 2,887,471 2,817,476 Less: Inventory reserves (106,127 ) (74,652 ) Inventories-Net $ 13,556,512 $ 11,482,701

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	3 Months Ended
	Mar. 31, 2019
Prepaid Expenses And Other Current Assets
PREPAID EXPENSES AND OTHER CURRENT ASSETS	5. PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets total $2,832,174 and $2,299,375, at March 31, 2019 and December 31, 2018, respectively, and consist mainly of prepaid advertising, prepaid insurance, prepaid slotting fees and net deposits on purchases.

NOTE RECEIVABLE

NOTE RECEIVABLE	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
NOTE RECEIVABLE	6. NOTE RECEIVABLE Note receivable consists of the following at: March 31, December 31, 2019 2018 Note Receivable-Current $ 1,224,529 $ - Note Receivable-Non-Current 11,020,766 - Total Note Receivable $ 12,245,295 $ - On January 1, 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng will repay the market investment Celsius has made into China to date, over a five-year period, under an unsecured, interest-bearing note receivable (“Note”). The initial outstanding principal under the Note was approximately $12.2 million, which was recorded as Other Income on the Consolidated Statements of Operations for the three months ended March 31, 2019. The amount recognized considered the net of the balances of the accounts receivable, accounts payable and accrued expenses, as well as the marketing investments that were performed in the China market. Scheduled principal payments plus accrued interest are due annually on March 31 of each year starting in 2020. The Note is recorded at amortized cost basis and accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. For the three months ended March 31, 2019, the weighted average interest rate was 3.21% and interest income was $96,000. The Company assesses the Note for impairment periodically by evaluating whether it is probable that the Company will be unable to collect all the contractual interest and principal payments as scheduled in the Note agreement, based on historical experience about Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At March 31, 2019, the Note was not deemed to be impaired.

LEASES

LEASES	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
LEASES	7. LEASES In February 2016, the FASB issued Accounting Standards Update 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires lessees to recognize a right-of-use (ROU) asset and lease liability in the balance sheet for all leases, including operating leases with terms of more than twelve months. The Company adopted ASU No. 2016-02, as amended, effective January 1, 2019. We recognized a ROU asset and a corresponding lease liability measured based on the present value of the future minimum lease payments utilizing our incremental borrowing rate as the basis for our computations. As of January 1, 2019, we recognized Right to use assets in the amount of $259,358 and a corresponding liability. The asset is being amortized over the life of the lease agreement. As of March 31, 2019, the value of the asset amounted to $223,991. The adoption of the guidance did not have a material impact on our Statement of Operations or Statement of Cash flows. The ROU represents our right to utilize the corresponding asset for the lease term and the related lease liability translates into an obligation to related to the lease payments. The operating lease liability as of March 31, 2019 amounted to $226,634 of which the short-term value amounted to $139,042 and the long-term portion was $87,592. Company entered into an office lease with a related party effective October 2015. The monthly rent amounts to $12,452 per month until October 2019 and then increases to $12,826 per month until the termination of the lease in October 2020. As of March 31, 2019, the remaining lease term is 19 months and the discount rate is 5%. Future annual minimum cash payments required under this operating type lease as of March 31, 2019 are as follows: Future Minimum Lease Payments 2019 $ 112,818 2020 128,259 Total Minimum Lease Payments $ 241,077 Less: Amount representing interest (14,443 ) Present value of lease liabilities $ 226,634

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	8. PROPERTY AND EQUIPMENT Property and equipment consist of the following at: March 31, December 31, 2019 2018 Furniture and equipment $ 451,576 $ 451,576 Less: accumulated depreciation (348,483 ) (329,722 ) Total $ 103,093 $ 121,854 Depreciation expense amounted to $18,761 and $7,953 during the three months ended March 31, 2019 and 2018, respectively

ACCOUNTS PAYABLE AND ACCRUED EX

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	3 Months Ended
	Mar. 31, 2019
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following at: March 31, December 31, 2019 2018 Accounts payable $ 5,749,943 $ 5,825,446 Accrued expenses 3,277,116 9,019,765 Total $ 9,027,059 $ 14,845,211

OTHER CURRENT LIABILITIES

OTHER CURRENT LIABILITIES	3 Months Ended
	Mar. 31, 2019
Deferred Revenue And Other Current Liabilities
OTHER CURRENT LIABILITIES	10. OTHER LIABILITIES Other current liabilities consist of the following at: March 31, December 31, 2019 2018 Other Liabilities $ 65,395 $ 19,933 Total $ 65,395 $ 19,933

NOTES PAYABLE - RELATED PARTY

NOTES PAYABLE - RELATED PARTY	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
NOTES PAYABLE - RELATED PARTY	11. NOTES PAYABLE - RELATED PARTIES Line of credit convertible note payable - related parties consists of the following as of: March 31, December 31, 2019 2018 Note Payable – line of credit In July 2010, the Company entered into a line of credit note payable with a related party and major shareholder which carries interest of five percent per annum paid quarterly. The Company can borrow up to $9,500,000. The Company has pledged all its assets as security for the line of credit. The note matures in January 2020, at which time the principal amount is due. During April 2015, the Company issued $4,000,000 of convertible series D preferred series in exchange for cancellation of $4,000,000 of this line, reducing the amount to $4,500,000. During March 2018, the Company issued $1,000,000 of common stock in exchange for cancellation of $1,000,000 of this line, reducing the amount to $3,500,000. In December 2018, the company amended and restated the note payable into a convertible loan agreement continuing to carry a five percent per annum interest but payable semi-annually. As a result, of this substantial modification which was treated as a debt extinguishment, a new liability was established and a loss of $377,0418 on the extinguishment of debt was recognized. The Company can now borrow up to $5.0 million. The note matures in December 2020. In January 2019, the company increased the borrowed amount by $1,500,000. The unamortized discount of the note as of March 2019 amounted to $149,161. The balance at March 31, 2019 is convertible into 1,491,338 shares at a conversion price of $3.40 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. Long-term portion $ 4,850,839 $ 3,500,000 March 31, December 31, 2019 2018 Convertible Note Payable -In December 2018, the Company entered into a convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $3.0 million. This note had an unamortized discount of $283,500 and $324,371 as of March 31, 2019 and as of December 31, 2018, respectively. The note matures in December 2020. The balance at March 31, 2019 is convertible into 1,002,553 shares at a fixed conversion price of $3.04 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. 2,716,500 2,675,629 -In December 2018, the Company entered into a line of credit convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $2.0 million. This note had an unamortized discount of $188,685 and $216,248 as of March 31, 2019 and as of December 31, 2018, respectively. The note matures in December 2020. The balance at March 31, 2019 is convertible into 668,369 shares at a fixed conversion price of $3.04 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. 1,811,315 1,783,752 Long-term portion-Net of Discount $ 4,527,815 $ 4,459,381

PREFERRED STOCK - RELATED PARTY

PREFERRED STOCK - RELATED PARTY	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
PREFERRED STOCK - RELATED PARTY	12. PREFERRED STOCK – RELATED PARTY The Company entered into a securities purchase agreement with CDS Ventures of South Florida, LLC (“CDS”) and CD Financial, LLC (“CD”). CDS and CD are limited liability companies which are affiliates of Carl DeSantis, the Company’s principal shareholder. The Company issued 2,200 shares of its Series C Preferred Stock (the “Preferred C Shares”) in exchange for the conversion of a $550,000 short term loan from CDS and the conversion of $1,650,000 in indebtedness under the Company’s line of credit with CD (the “CD Line of Credit”). The Preferred C Shares are convertible into our common stock at the option of the holder thereof at a conversion price of $0.52 per share at any time until December 31, 2018, at which time they will automatically convert into shares of our common stock determined by dividing the liquidation preference of $1,000 per Preferred C Share by the conversion price then in effect. The conversion price is subject to adjustment in the event of stock dividends, stock splits and similar events. The Preferred C Shares accrue cumulative annual dividends at the rate of 6% per annum, payable by the issuance of additional Preferred C Shares. The holder of Preferred C Shares votes on an “as converted” basis, together with holders of common stock as a single class on all matters presented to shareholders for a vote, except as required by law. In April 2015, the Company issued 180 Preferred C Shares valued at $180,000 in settlement of $180,000 in accrued preferred C dividends. In October 2017, the Company issued 383 Preferred C Shares valued at $383,000 in settlement of $383,000 in accrued preferred C dividends. As of December 31, 2018, $255,903 of dividends has been accrued and converted into 256 of additional Preferred C. The Preferred C Shares matured on December 31, 2018 and were exchanged for 5,806,022 shares of Company common stock. On April 16, 2015, the Company entered into an amendment to its existing Loan and Security Agreement (the “Amendment”) with CD an affiliate of CDS Ventures and Mr. DeSantis. Pursuant to the Amendment, the outstanding principal amount of the CD note payable was reduced by $4.0 million, which amount was converted into 4,000 shares of a newly-designated Series D Preferred Stock (the “Preferred D Shares”). This related party was given a conversion price of $0.86 per common share, whereas other investors purchased common shares at $0.89 in the private placement, as discussed in note 12. The difference of $0.03 per share, which resulted in $139,535, was recorded as a dividend in accordance with ASC 470-20-35, subsequent measurement for debt with conversion and other options. The Preferred D Shares are convertible into our common stock at the option of the holder thereof at a conversion price of $0.86 per share until the earlier of the January 2, 2021 due date of our note payable with CD Financial or such earlier date as the note payable is satisfied (the “Maturity Date”). The conversion price is subject to adjustment in the event of stock dividends, stock splits and similar events. The Preferred D Shares accrue cumulative annual cash dividends at the rate of 5% per annum, payable quarterly in cash and have a liquidation preference of $1,000 per share. On the Maturity Date, the Preferred D Shares automatically convert into shares of our common stock in a number determined by dividing the $1,000 per Preferred D Share liquidation preference plus any accrued but unpaid dividends, by the conversion price then in effect. The Holder shall have the right, at its election, to require the Company to redeem all or any portion of the shares held by the holder in exchange for cash or common stock upon the occurrence of certain events which management believes are under the control of the Company. As of March 31, 2018, none of the contingent events have occurred and in accordance with ASC-480-10-25 “Distinguishing Liabilities from Equity” and Regulation S-X-Rule 5-02-27, the Company has classified these shares as permanent equity. The Preferred D Shares may also be redeemed by us at any time on or after December 31, 2017, at a redemption price equal to 104% of the liquidation preference. The holder of the Preferred D Shares votes on an “as converted” basis, together with holders of common stock as a single class on all matters presented to shareholders for a vote, except as required by law. In March 2018, the Preferred D shares were converted into 4,651,163 shares of common stock.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	13. RELATED PARTY TRANSACTIONS The Company’s office is rented from a company affiliated with CD Financial, LLC which is controlled by one of our shareholders Carl DeSantis. Currently, the lease expires on October 2020 with monthly rent of $12,452. The rental fee is commensurate with other properties available in the market. Other related party transactions are discussed in Notes 11 and 12

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
STOCKHOLDERS' EQUITY	14. STOCKHOLDERS’ EQUITY Issuance of common stock pursuant to services performed On July 19, 2018 the Company settled a legal matter that was filed in Superior Court of the State of California, Los Angeles County, by Statewide Beverage Company, Inc. (“Statewide”), a former distributor of the Company’s products. As part of the settlement the Company issued 60,000 shares of “restricted” stock, to the ten plaintiffs involved in the complaint for a total fair value of $279,600, or $4.66 per share, representing the closing stock price on the settlement date. The stock “restriction” pertains to the shareholders intention of using the shares for investment purposes only and not with a view to distribute or resell the shares or any part thereof or interest therein. However, the Stockholder’s rights allow for the selling or otherwise disposal of all or part of the shares pursuant to an exemption under the Securities Act of 1933, as amended (the Securities Act”) and applicable state securities laws or pursuant to registration of the share under such laws. Issuance of common stock pursuant to exercise of stock options During the three months ended March 31, 2019, the Company issued an aggregate of 195,857 shares of its common stock pursuant to the exercise of stock options granted under the Company’s 2015 Stock Incentive Plan. The Company received aggregate proceeds of $24,760 for 80,750 options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. During the three months ended March 31, 2018, the Company issued an aggregate of 604,113 shares of its common stock pursuant to the exercise of stock options granted under the Company’s 2006 Stock Incentive Plan. The Company received aggregate proceeds of $142,627 for options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. Issuance of preferred stock pursuant to private placement In March 2018, the 4,000 preferred D shares were converted into 4,651,163 shares of common stock. Refer to Note 12 for discussion on preferred stock issuances.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2019
Share-based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	15. STOCK-BASED COMPENSATION The Company adopted an Incentive Stock Plan on January 18, 2007. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. While the plan terminates 10 years after the adoption date, issued options have their own schedule of termination. During 2013, the majority of the shareholders approved to increase the total available shares in the plan from 2.5 million to 3.5 million shares of common stock. During May 2014, the majority of the shareholders approved to increase the total available shares in the plan from 3.5 million to 4.25 million shares of common stock, during February 2015, the majority of the shareholders approved to increase the total available shares in the plan from 4.25 million to 4.6 million shares of common stock and during April 2015, the majority of the shareholders approved to increase the total available shares in the plan from 4.6 million to 5.1 million shares of common stock. Upon exercise, shares of new common stock are issued by the Company. The Company adopted the 2015 Stock Incentive Plan on April 30, 2015. This plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to Awards issued. The 2015 Plan permits the grant of options and shares for up to 5,000,000 shares. In addition, there is a provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2017. As of March 31, 2019, 6,901,360 shares are available. Under the 2015 Stock Option Plan the Company has issued options to purchase approximately 5.64 million shares at an average price of $3.85 per share with a fair value of $5.97 million. For the three months ended March 31, 2019 and 2018, the Company issued options to purchase 1.27 million and 1.1 million shares. For the three months ended March 31, 2019 and 2018, the Company recognized an expense of approximately $1,358,503 and $770,862, respectively, of non-cash compensation expense (included in General and Administrative expense in the accompanying Consolidated Statement of Operations) determined by application of a Black Scholes option pricing model with the following inputs: exercise price, dividend yields, risk-free interest rate, and expected annual volatility. As of March 31, 2019, the Company had approximately $9,652,000 of unrecognized pre-tax non-cash compensation expense, which the Company expects to recognize, based on a weighted-average period of 3 years. The Company used straight-line amortization of compensation expense over the two to three-year requisite service or vesting period of the grant. There are options to purchase approximately 2.95 million shares that are vested as of March 31, 2019. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black - Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: Three months ended March 31, 2019 2018 Expected volatility 71%-121% 62.91 – 62.98 Expected term 4.02-4.64 Years 4.77 – 5 Years Risk-free interest rate 2.55% - 2.72% 2.56% - 2.57% Forfeiture Rate 0.00% 0.00% Expected dividend yield 0.00% 0.00% The expected volatility was determined with reference to the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant. A summary of the status of the Company’s outstanding stock options as of March 31, 2019 and changes during the period ending on that date is as follows: Weighted Average Aggregate Average Exercise Intrinsic Remaining Shares (000’s) Price Value (000’s) Term (Yrs) Options Balance at December 31, 2018 4,840 $ 3.04 $ 5,338 5.05 Granted 1,269 $ 3.73 Exercised (342 ) $ 1.17 Forfeiture and cancelled (262 ) $ 2.67 At March 31, 2019 5,505 $ 3.33 $ 5,968 6.05 Exercisable at March 31, 2019 2,951 $ 2.45 The following table summarizes information about employee stock options outstanding at March 31, 2019: Outstanding Options Vested Options Number Number Outstanding Weighted Weighted Exercisable Weighted Weighted Range of at Average Average at Average Average Exercise March 31, Remaining Exercise March 31, Exercise Remaining Price 2019 (000’s) Term Price 2019 (000’s) Price Term $0.20 - $0.53 399 3.83 $ 0.27 399 $ 0.27 3.83 $0.65 - $1.80 792 1.01 $ 0.84 792 $ 0.84 1.01 $1.83 - $2.84 626 3.19 $ 2.06 612 $ 2.06 3.18 $3.20 - $6.20 3,680 7.87 $ 4.40 1,140 4.48 6.88 $7.20 - $22.00 8 0.38 $ 10.36 8 $ 10.36 0.38 Outstanding options 5,505 6.05 $ 3.33 2,951 $ 2.45 4.11 Restricted Stock Awards Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holder of a restricted stock award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a shareholder of the Company, including the right to vote the shares. The value of stock awards that vest over time was established by the market price on the date of its grant. A summary of the Company’s restricted stock activity for the three months ended March 31, 2019 For the Three Months ended March 31, 2019 March 31, 2018 Weighted Weighted Average Average (000’s) Grant Date (000’s) Grant Date Shares Fair Value Shares Fair Value Unvested at beginning of period 38,889 $ — — — Granted 3.64 100,000 3.64 Vested 8,333 — 33,333 — Unvested at end of period 30,556 $ 3.64 66,667 3.64 Unrecognized compensation expense related to outstanding restricted stock awards to employees and directors as of March 31, 2019

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	16. COMMITMENTS AND CONTINGENCIES The Company has entered into distribution agreements with liquidated damages in the event the Company cancels the distribution agreements without cause. Cause has been defined in various ways. It is management’s belief that no such agreement has created any liability as of March 31, 2019. On December 18, 2018, Rockstar, Inc. (“ Rockstar On April 8, 2019, Daniel Prescod filed suit against Celsius Holdings, Inc., Case No. 19STCV09321, pending in Superior Court for the State of California, County of Los Angeles (the “Prescod Litigation”). Daniel Prescod asserts that the Company’s use of citric acid in its products while simultaneously claiming “no preservatives” violates California Consumer Legal Remedies Act, California Business and Professions Code Section 17200, et seq., and California Business and Professions Code Section 17500, et seq., because citric acid acts as a preservative. The Company does not use citric acid as a preservative in its products, but rather as a flavoring, and therefore it believes that its “no preservatives” claim is fair and not deceptive. The Company intends to contest the claims vigorously. Since this matter is still in its initial stages, it is impossible to predict the outcome at this time. In addition to the foregoing, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	17. SUBSEQUENT EVENTS Between April 1, 2019 and May 9, 2019, the Company issued an aggregate of 109,488 shares of its common stock pursuant to the exercise of stock options granted under the Company’s 2015 Stock Incentive Plan. The Company received cash in the amount of $56,400 for options exercised.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation – US GAAP Commission
Significant Estimates	Significant Estimates
Segment Reporting	Segment Reporting Disclosed About Segments of an Enterprise and Related Information.) Our chief operating decision-maker is considered to be our Chief Executive Officer (CEO). The CEO reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The financial information reviewed by the CEO is identical to the information presented in the accompanying consolidated statement of operations. Therefore, the Company has determined that it operates in a single operating segment. For the three months ended March 31, 2019 and 2018 all material assets and revenues of the Company where in the United States except as disclosed in Note 2.
Concentrations of Risk	Concentrations of Risk The Company uses single supplier relationships for its raw materials purchases and filling capacity, which potentially subjects the Company to a concentration of business risk. If these suppliers had operational problems or ceased making product available to the Company, operations could be adversely affected. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At March 31, 2019, the Company had approximately $2.5 million in excess of the Federal Deposit Insurance Corporation limit. For the three months ended March 31, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 17.9 % 18.0 % B* 0.1 % 11.6 % All other 82.0 % 70.4 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in China. Revenues from all other customers were mainly derived in the United States. At March 31, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 41.1 % 41.5 % All other 58.9 % 58.5 % Total 100.0 % 100.0 % *Receivables from customer A are derived from a customer located in Sweden.
Cash Equivalents	Cash Equivalents
Accounts Receivable	Accounts Receivable
Inventories	Inventories
Property and Equipment	Property and Equipment
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
Revenue Recognition	Revenue Recognition Revenue is derived from the sale of beverages. The Company recognizes revenue when obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives the Company offers to its customers and their customers. Any discounts, slotting fees, sales incentives or similar arrangements with the customer are estimated at time of sale and deducted from revenue. Sales taxes and other similar taxes are excluded from revenue.
Customer Advance	Customer Advances
Advertising Costs	Advertising Costs
Research and Development	Research and Development
Foreign Currency Translation	Foreign Currency Translation-Chinese Yuan Renminbi — As of and for the three months ended March 31, 2019 and March 31, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: March 31, 2019 March 31, 2018 Exchange rate on balance sheet dates USD : CNY exchange rate 6.71 6.29 Average exchange rate for the period USD : CNY exchange rate 6.75 6.36
Fair Value of Financial Instruments	Fair Value of Financial Instruments
Fair Value Measurements	Fair Value Measurements Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. Other than these noted previously, the Company did not have any other assets or liabilities measured at fair value at March 31, 2019 and December 31, 2018.
Income Taxes	Income Taxes — Accounting for Uncertain Income Tax Positions. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits. The Company has adopted ASC 740-10-25 Definition of Settlement,
Earnings per Share	Earnings per Share There were no other dilutive common shares equivalents, including convertible notes and warrants, as no common share equivalents had an exercise price below the ending closing price of the year. The effects of dilutive instruments have not been presented as the effects would be anti-dilutive.
Share-Based Payments	Share-Based Payments
Cost of Sales	Cost of Sales
Operating Expenses	Operating Expenses
Shipping and Handling Costs	Shipping and Handling Costs
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. In June 2016, the FASB issued ASU No. 2016-13 & updated in Nov 2018 ASU 2018-19, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. ASU 2016-13 is effective for fiscal years and interim reporting periods within those years beginning after December 15, 2019. Early adoption is permitted after fiscal years beginning December 15, 2018. The Company is currently evaluating the potential impact of adopting this guidance on our financial statements. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework Changes to the Disclosure Requirements for Fair Value Measurement. The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820. The ASU is effective for the Registrants for fiscal years beginning after December 15, 2019, and interim periods therein. Early adoption is permitted. The Company is currently assessing the impact of this standard on their Financial Statements. All new accounting pronouncements issued but not yet effective are not expected to have a material impact on our results of operations, cash flows or financial position with the exception of the updated previously disclosed above, there have been no new accounting pronouncements not yet effective that have significance to our consolidated financial statements.
Liquidity	Liquidity In addition to cash flow from operations, our primary sources of working capital have been private placements of our securities and our credit facilities with CD Financial, LLC (“CD Financial”), an affiliate of Carl DeSantis, a principal shareholder of the Company, as well as Charmnew Limited and Grieg International Limited. Charmnew Limited is an existing shareholder of record affiliated with Li Ka Shing, one of our principal shareholders. Grieg International Limited is an existing shareholder of record affiliated with Chau Hoi Shuen Solina, one of our principal shareholders. If our sales volumes do not meet our projections, expenses exceed our expectations, our plans change, we may be unable to generate enough cash flow from operations to cover our working capital requirements. In such case, we may be required to adjust our business plan, by reducing marketing, lower our working capital requirements and reduce other expenses or seek additional financing.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Schedule of revenue & accounts receivable with customers	For the three months ended March 31, 2019 and 2018, the Company had the following 10 percent or greater concentrations of revenue with its customers: 2019 2018 A* 17.9 % 18.0 % B* 0.1 % 11.6 % All other 82.0 % 70.4 % Total 100.0 % 100.0 % Revenues from customer A are derived from a customer located in Sweden and customer B are derived from a customer located in China. Revenues from all other customers were mainly derived in the United States. At March 31, 2019 and December 31, 2018, the Company had the following 10 percent or greater concentrations of accounts receivable with its customers: 2019 2018 A* 41.1 % 41.5 % All other 58.9 % 58.5 % Total 100.0 % 100.0 % *Receivables from customer A are derived from a customer located in Sweden.
Schedule of exchange rates	As of and for the three months ended March 31, 2019 and March 31, 2018, the exchange rates used to translate amounts in Chinese Yuan into USD for the purposes of preparing the consolidated financial statements were as follows: March 31, 2019 March 31, 2018 Exchange rate on balance sheet dates USD : CNY exchange rate 6.71 6.29 Average exchange rate for the period USD : CNY exchange rate 6.75 6.36

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2019
Revenue from Contract with Customer [Abstract]
Schedule of net sales by reporting segment	Information about the Company’s net sales by reporting segment for the three months ended March 31, 2019 and 2018 are as follows: For the three months ended March 31, March 31, 2019 2018 North America $ 11,397,862 $ 8,096,080 Europe 2,999,664 2,506,433 Asia 52,764 1,389,277 Other 35,360 68,186 Net sales $ 14,485,650 $ 12,059,976

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories consist of the following at: March 31, December 31, 2019 2018 Finished goods $ 10,775,168 $ 8,739,877 Raw Materials 2,887,471 2,817,476 Less: Inventory reserves (106,127 ) (74,652 ) Inventories-Net $ 13,556,512 $ 11,482,701

NOTE RECEIVABLE (Tables)

NOTE RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Schedule of note receivable	Note receivable consists of the following at: March 31, December 31, 2019 2018 Note Receivable-Current $ 1,224,529 $ - Note Receivable-Non-Current 11,020,766 - Total Note Receivable $ 12,245,295 $ -

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Future annual minimum cash payments required under operating lease	Future annual minimum cash payments required under this operating type lease as of March 31, 2019 are as follows: Future Minimum Lease Payments 2019 $ 112,818 2020 128,259 Total Minimum Lease Payments $ 241,077 Less: Amount representing interest (14,443 ) Present value of lease liabilities $ 226,634

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Property and equipment consist of the following at: March 31, December 31, 2019 2018 Furniture and equipment $ 451,576 $ 451,576 Less: accumulated depreciation (348,483 ) (329,722 ) Total $ 103,093 $ 121,854

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	3 Months Ended
	Mar. 31, 2019
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued expenses	Accounts payable and accrued expenses consist of the following at: March 31, December 31, 2019 2018 Accounts payable $ 5,749,943 $ 5,825,446 Accrued expenses 3,277,116 9,019,765 Total $ 9,027,059 $ 14,845,211

OTHER CURRENT LIABILITIES (Tabl

OTHER CURRENT LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2019
Deferred Revenue, Current [Abstract]
Schedule of other current liabilities	Other current liabilities consist of the following at: March 31, December 31, 2019 2018 Other Liabilities $ 65,395 $ 19,933 Total $ 65,395 $ 19,933

NOTES PAYABLE - RELATED PARTY (

NOTES PAYABLE - RELATED PARTY (Tables)	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Schedule of note payable - related parties	Line of credit convertible note payable - related parties consists of the following as of: March 31, December 31, 2019 2018 Note Payable – line of credit In July 2010, the Company entered into a line of credit note payable with a related party and major shareholder which carries interest of five percent per annum paid quarterly. The Company can borrow up to $9,500,000. The Company has pledged all its assets as security for the line of credit. The note matures in January 2020, at which time the principal amount is due. During April 2015, the Company issued $4,000,000 of convertible series D preferred series in exchange for cancellation of $4,000,000 of this line, reducing the amount to $4,500,000. During March 2018, the Company issued $1,000,000 of common stock in exchange for cancellation of $1,000,000 of this line, reducing the amount to $3,500,000. In December 2018, the company amended and restated the note payable into a convertible loan agreement continuing to carry a five percent per annum interest but payable semi-annually. As a result, of this substantial modification which was treated as a debt extinguishment, a new liability was established and a loss of $377,0418 on the extinguishment of debt was recognized. The Company can now borrow up to $5.0 million. The note matures in December 2020. In January 2019, the company increased the borrowed amount by $1,500,000. The unamortized discount of the note as of March 2019 amounted to $149,161. The balance at March 31, 2019 is convertible into 1,491,338 shares at a conversion price of $3.40 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. Long-term portion $ 4,850,839 $ 3,500,000 March 31, December 31, 2019 2018 Convertible Note Payable -In December 2018, the Company entered into a convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $3.0 million. This note had an unamortized discount of $283,500 and $324,371 as of March 31, 2019 and as of December 31, 2018, respectively. The note matures in December 2020. The balance at March 31, 2019 is convertible into 1,002,553 shares at a fixed conversion price of $3.04 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. 2,716,500 2,675,629 -In December 2018, the Company entered into a line of credit convertible note payable with a related party and shareholder which carries interest of five percent per annum paid semi-annually. The Company can borrow up to $2.0 million. This note had an unamortized discount of $188,685 and $216,248 as of March 31, 2019 and as of December 31, 2018, respectively. The note matures in December 2020. The balance at March 31, 2019 is convertible into 668,369 shares at a fixed conversion price of $3.04 per share which was determined based on the average of the closing price for the shares during the ten (10) business days prior to the Advance Date, less a discount of 10%. 1,811,315 1,783,752 Long-term portion-Net of Discount $ 4,527,815 $ 4,459,381

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2019
Share-based Payment Arrangement [Abstract]
Schedule of black - scholes option-pricing model valuation assumption	The calculation of the fair value of the awards using the Black - Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: Three months ended March 31, 2019 2018 Expected volatility 71%-121% 62.91 – 62.98 Expected term 4.02-4.64 Years 4.77 – 5 Years Risk-free interest rate 2.55% - 2.72% 2.56% - 2.57% Forfeiture Rate 0.00% 0.00% Expected dividend yield 0.00% 0.00%
Schedule of outstanding stock options	A summary of the status of the Company’s outstanding stock options as of March 31, 2019 and changes during the period ending on that date is as follows: Weighted Average Aggregate Average Exercise Intrinsic Remaining Shares (000’s) Price Value (000’s) Term (Yrs) Options Balance at December 31, 2018 4,840 $ 3.04 $ 5,338 5.05 Granted 1,269 $ 3.73 Exercised (342 ) $ 1.17 Forfeiture and cancelled (262 ) $ 2.67 At March 31, 2019 5,505 $ 3.33 $ 5,968 6.05 Exercisable at March 31, 2019 2,951 $ 2.45
Schedule of employee stock options outstanding	The following table summarizes information about employee stock options outstanding at March 31, 2019: Outstanding Options Vested Options Number Number Outstanding Weighted Weighted Exercisable Weighted Weighted Range of at Average Average at Average Average Exercise March 31, Remaining Exercise March 31, Exercise Remaining Price 2019 (000’s) Term Price 2019 (000’s) Price Term $0.20 - $0.53 399 3.83 $ 0.27 399 $ 0.27 3.83 $0.65 - $1.80 792 1.01 $ 0.84 792 $ 0.84 1.01 $1.83 - $2.84 626 3.19 $ 2.06 612 $ 2.06 3.18 $3.20 - $6.20 3,680 7.87 $ 4.40 1,140 4.48 6.88 $7.20 - $22.00 8 0.38 $ 10.36 8 $ 10.36 0.38 Outstanding options 5,505 6.05 $ 3.33 2,951 $ 2.45 4.11
Summary of restricted stock awards	A summary of the Company’s restricted stock activity for the three months ended March 31, 2019 For the Three Months ended March 31, 2019 March 31, 2018 Weighted Weighted Average Average (000’s) Grant Date (000’s) Grant Date Shares Fair Value Shares Fair Value Unvested at beginning of period 38,889 $ — — — Granted 3.64 100,000 3.64 Vested 8,333 — 33,333 — Unvested at end of period 30,556 $ 3.64 66,667 3.64

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - 10% or Greater Revenue [Member]		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Concentration Risk [Line Items]
Total		100.00%	100.00%
Customer A [Member]
Concentration Risk [Line Items]
Total	[1]	17.90%	18.00%
Customer B [Member]
Concentration Risk [Line Items]
Total		0.10%	11.60%
All Other [Member]
Concentration Risk [Line Items]
Total		82.00%	70.40%
[1]	Revenues from customer A are derived from a customer located in Sweden. Revenues from all other customers were mainly derived from the United States. Receivables from customer B are obtained from a customer located in China.

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - 10% or Accounts Receivable [Member]		3 Months Ended	12 Months Ended
		Mar. 31, 2019	Dec. 31, 2018
Concentration Risk [Line Items]
Total		100.00%	100.00%
Customer A [Member]
Concentration Risk [Line Items]
Total	[1]	41.10%	41.50%
All Other [Member]
Concentration Risk [Line Items]
Total		58.90%	58.50%
[1]	Revenues from customer A are derived from a customer located in Sweden. Revenues from all other customers were mainly derived from the United States. Receivables from customer B are obtained from a customer located in China.

BASIS OF PRESENTATION AND SUM_6

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Accounting Policies [Abstract]
Exchange rate on balance sheet dates	6.71	6.29
Average exchange rate for the period	6.75	6.36

BASIS OF PRESENTATION AND SUM_7

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Amount excess of FDIC limit	$ 2,500,000
Allowance for doubtful accounts	260,649		$ 183,000
Inventory reserve	106,127		74,652
Advertising expense	1,200,000	$ 4,000,000
Research and development expense	$ 103,000	121,000
Number of shares available	6,901,360
Freight expense	$ 1,300,000	1,100,000
Conversion Of Convertible Debt into common stock	3,162,260
Accumulated deficit	(61,724,097)		$ (73,380,691)
Net (loss) available to common stockholders	11,656,594	(2,959,195)
Net cash used in operating activities	$ (6,793,712)	$ (4,275,713)
Minimum [Member]
Useful life	3 years
Maximum [Member]
Useful life	7 years

REVENUE (Details)

REVENUE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net sales	$ 14,485,650	$ 12,059,976
North America [Member]
Net sales	11,397,862	8,096,080
Europe [Member]
Net sales	2,999,664	2,506,433
Asia [Member]
Net sales	52,764	1,389,277
Other [Member]
Net sales	$ 35,360	$ 68,186

REVENUE (Details Narrative)

REVENUE (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues	$ 14,485,650	$ 12,059,976
License Agreement [Member]
Royalty fees	6,900,000
Revenues	$ 90,000

INVENTORIES (Details)

INVENTORIES (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 10,775,168	$ 8,739,877
Raw Materials	2,887,471	2,817,476
Less: Inventory reserves	(106,127)	(74,652)
Inventories, net	$ 13,556,512	$ 11,482,701

PREPAID EXPENSES AND OTHER CU_2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
D3M Licensing Group [Member] | Prepaid Consulting Agreement [Member]
Prepaid expenses and other current assets	$ 2,832,174	$ 2,299,375

NOTE RECEIVABLE (Details)

NOTE RECEIVABLE (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Notes to Financial Statements
Note Receivable-Current	$ 1,224,529
Note Receivable-Non-Current	11,020,766
Total Note Receivable	$ 12,245,295

NOTE RECEIVABLE (Details Narrat

NOTE RECEIVABLE (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Notes to Financial Statements
Note Receivable	$ 12,245,295
Note Receivable description	Scheduled principal payments plus accrued interest are due annually on March 31 of each year starting in 2020. The Note is recorded at amortized cost basis and accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million.
Weighted average interest rate	3.21%
Interest income	$ 96,000

LEASES (Details)

LEASES (Details)	Mar. 31, 2019USD ($)
Leases [Abstract]
2019	$ 112,818
2020	128,259
Total Minimum Lease Payments	241,077
Less: Amount representing interest	(14,443)
Present value of lease liabilities	$ 226,634

LEASE (Details Narrative)

LEASE (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Jan. 02, 2019	Dec. 31, 2018
Leases [Abstract]
Right to use assets	$ 223,991	$ 259,358
Operating lease liability	226,634
Short-term operating lease liability	139,042
Long term operating lease liability	$ 87,592
Lease description	The monthly rent amounts to $12,452 per month until October 2019 and then increases to $12,826 per month until the termination of the lease in October 2020.
Lease term		19 months
Discount rate		5.00%

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Less: accumulated depreciation	$ (348,483)	$ (329,722)
Total	103,093	121,854
Furniture and Equipment [Member}
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 451,576	$ 451,576

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 18,761	$ 7,953

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accounts payable	$ 5,749,943	$ 5,825,446
Accrued expenses	3,277,116	9,019,765
Total	$ 9,027,059	$ 14,845,211

OTHER LIABILITIES (Details)

OTHER LIABILITIES (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Deferred Revenue, Current [Abstract]
Other Liabilities	$ 65,395	$ 19,933
Total	$ 65,395	$ 19,933

NOTES PAYABLE - RELATED PARTIES

NOTES PAYABLE - RELATED PARTIES (Details) - USD ($)	1 Months Ended				3 Months Ended
	Dec. 31, 2018	Mar. 31, 2018	Apr. 30, 2015	Jul. 31, 2010	Mar. 31, 2019
Long-term portion	$ 3,500,000				$ 4,850,839
5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | CD Financial, LLC [Member]
Long-term portion	$ 3,500,000				4,850,839
Maximum borrowing capacity				$ 9,500,000	5,000,000
Debt maturity date	Dec. 31, 2020			Jan. 2, 2020
Loss on debt extinguishment	$ (3,770,418)
Conversion of common stock	1,491,338
Unamortized discount					$ 149,161
Conversion price					$ 3.40
Discount rate	10.00%
5% Note Payable - Line of Credit [Member] | Carl DeSantis [Member] | CD Financial, LLC [Member] | 5% Series D Preferred Stock [Member]
Number of shares issued upon debt cancellation		1,000,000	4,000,000
Debt cancelled amount		$ 1,000,000	$ 4,000,000
Increased in borrowed amount					$ 1,500,000

NOTES PAYABLE - RELATED PARTI_2

NOTES PAYABLE - RELATED PARTIES (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Convertible Note Payable	$ 4,527,815	$ 4,459,381
5% Convertible Note Payable [Member] | Related Party And Shareholder [Member]
Convertible Note Payable	2,716,500	2,675,629
Maximum borrowing capacity	3,000,000
Unamortized discount	$ 283,500	324,371
Debt maturity date	Dec. 31, 2020
Conversion of common stock	1,002,553
Conversion price	$ 3.04
Discount rate	10.00%
5% Line of Credit Convertible Note Payable [Member] | Related Party And Shareholder [Member]
Convertible Note Payable	$ 1,811,315	1,783,752
Maximum borrowing capacity	2,000,000
Unamortized discount	$ 188,685	$ 216,248
Debt maturity date	Dec. 31, 2020
Conversion of common stock	668,369
Conversion price	$ 3.04
Discount rate	10.00%

PREFERRED STOCK - RELATED PAR_2

PREFERRED STOCK - RELATED PARTY (Details Narrative) - Carl DeSantis [Member] - USD ($)	Apr. 16, 2015	Aug. 26, 2013	Mar. 31, 2018	Oct. 31, 2017	Apr. 30, 2015	Dec. 31, 2018	Dec. 31, 2017
CD Financial, LLC [Member] | 5% Series D Preferred Stock [Member] | Amendment Loan and Security Agreement [Member]
Number of shares issued upon debt conversion	4,000
Conversion price (in dollars per share)	$ 0.86
Liquidation preference (in dollars per share)	$ 1,000
Accrued dividend	$ 139,535
Preferred stock redemption date	Jan. 2, 2020
Share price (in dollars per share)	$ 0.89
Dividend payable (in dollars per share)	$ 0.03
Preferred stock redemption price, percent	104.00%
Conversion of preferred stock into common stock			4,651,163
CD Financial, LLC [Member] | 5% Note Payable - Line of Credit [Member] | Amendment Loan and Security Agreement [Member]
Line of credit reduction borrowing capacity	$ 4,000,000
CD Financial, LLC [Member] | 5% Note Payable - Line of Credit [Member] | Securities Purchase Agreement [Member]
Original debt conversion amount		$ 1,650,000
CDS Ventures of South Florida, LLC & CD Financial, LLC [Member] | 6% Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of shares issued upon debt conversion		2,200
Conversion price (in dollars per share)		$ 0.52
Liquidation preference (in dollars per share)		$ 1,000
CDS Ventures of South Florida, LLC [Member] | 6% Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of shares issued upon accrued dividend				383	180
Value of shares issued upon accrued dividend				$ 383,000	$ 180,000
Accrued dividend						$ 255,903
Preferred stock redemption date							Dec. 31, 2018
Number of preferred stock converted						256
Conversion of preferred stock into common stock						5,806,022
CDS Ventures of South Florida, LLC [Member] | Short Term Loan [Member] | Securities Purchase Agreement [Member]
Original debt conversion amount		$ 550,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - CD Financial, LLC [Member] - Office [Member] - Carl DeSantis [Member]	3 Months Ended
	Mar. 31, 2019USD ($)
Lease expiration	2020-10
Monthly expense	$ 12,452

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
	Jul. 31, 2018	Mar. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Proceeds from Options exercised			$ 24,760	$ 142,023
Number of options exercised			342,000
Series D Preferred Stock [Member]
Number of preferred stock converted		4,000		4,000
Conversion of preferred stock into common stock		4,651,163
2006 Stock Incentive Plan [Member]
Number of option shares granted			195,857	604,113
Value of option shares granted			$ 24,760	$ 142,627
Proceeds from Options exercised			$ 24,760
Number of options exercised			80,750
Restricted Common Stock [Member] | Statewide [Member]
Fair value of shares issued upon services rendered	$ 279,600
Stock price (in dollars per share)	$ 4.66
Stock issued for settlement of legal matter	60,000

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Forfeiture Rate	0.00%	0.00%
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Expected volatility	71.00%	62.91%
Expected term	4 years 7 days	4 years 9 months 7 days
Risk-free interest rate	2.55%	2.56%
Maximum [Member]
Expected volatility	121.00%	62.98%
Expected term	4 years 7 months 21 days	5 years
Risk-free interest rate	2.72%	2.57%

STOCK-BASED COMPENSATION (Det_2

STOCK-BASED COMPENSATION (Details 1)	3 Months Ended
	Mar. 31, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Balance at beginning | shares	4,840,000
Granted | shares	1,269,000
Exercised | shares	(342,000)
Forfeiture and cancelled | shares	(262,000)
Balance at end | shares	5,505,000
Exercisable at end | shares	2,951,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Balance at beginning | $ / shares	$ 3.04
Granted | $ / shares	3.73
Exercised | $ / shares	1.17
Forfeiture and cancelled | $ / shares	2.67
Balance at end | $ / shares	3.33
Exercisable at end | $ / shares	$ 2.45
Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Roll Forward]
Balance at beginning | $	$ 5,338,000
Balance at end | $	$ 5,968,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Average Remaining Term [Roll Forward]
Balance at beginning	5 years 18 days
Balance at end	6 years 18 days

STOCK-BASED COMPENSATION (Det_3

STOCK-BASED COMPENSATION (Details 2)	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Outstanding Options
Number Outstanding at end | shares	5,505,000
Weighted Averaged Remaining Life	6 years 18 days
Weighted Averaged Exercise Price | $ / shares	$ 3.33
Vested Options
Number Exercisable at end | shares	2,951,000
Weighted Averaged Exercise Price | $ / shares	$ 2.45
Weighted Averaged Remaining Life	4 years 1 month 9 days
$0.20 - $0.53 [Member]
Outstanding Options
Number Outstanding at end | shares	399,000
Weighted Averaged Remaining Life	3 years 9 months 29 days
Weighted Averaged Exercise Price | $ / shares	$ 0.27
Vested Options
Number Exercisable at end | shares	399,000
Weighted Averaged Exercise Price | $ / shares	$ 0.27
Weighted Averaged Remaining Life	3 years 9 months 29 days
$0.65 - $1.80 [Member]
Outstanding Options
Number Outstanding at end | shares	792,000
Weighted Averaged Remaining Life	1 year 4 days
Weighted Averaged Exercise Price | $ / shares	$ 0.84
Vested Options
Number Exercisable at end | shares	792,000
Weighted Averaged Exercise Price | $ / shares	$ 0.84
Weighted Averaged Remaining Life	1 year 4 days
$1.83 - $2.84 [Member]
Outstanding Options
Number Outstanding at end | shares	626,000
Weighted Averaged Remaining Life	3 years 2 months 8 days
Weighted Averaged Exercise Price | $ / shares	$ 2.06
Vested Options
Number Exercisable at end | shares	612,000
Weighted Averaged Exercise Price | $ / shares	$ 2.06
Weighted Averaged Remaining Life	3 years 2 months 5 days
$3.20 - $6.20 [Member]
Outstanding Options
Number Outstanding at end | shares	3,680,000
Weighted Averaged Remaining Life	7 years 10 months 14 days
Weighted Averaged Exercise Price | $ / shares	$ 4.4
Vested Options
Number Exercisable at end | shares	1,140,000
Weighted Averaged Exercise Price | $ / shares	$ 4.48
Weighted Averaged Remaining Life	6 years 10 months 17 days
$7.20 - $22.00 [Member]
Outstanding Options
Number Outstanding at end | shares	8,000
Weighted Averaged Remaining Life	4 months 17 days
Weighted Averaged Exercise Price | $ / shares	$ 10.36
Vested Options
Number Exercisable at end | shares	8,000
Weighted Averaged Exercise Price | $ / shares	$ 10.36
Weighted Averaged Remaining Life	4 months 17 days

STOCK-BASED COMPENSATION (Det_4

STOCK-BASED COMPENSATION (Details 3) - $ / shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Number of Shares
Unvested at beginning of period	38,889,000
Restricted stock granted	0	100,000,000
Restricted stock vested	8,333,000	33,333,000
Unvested at end of period	30,556,000	66,667,000
Weighted Average Grant-Date Fair Value per Share
Unvested at beginning of period
Restricted stock granted	3.64	3.64
Restricted stock vested
Unvested at end of period	$ 3.64	$ 3.64

STOCK-BASED COMPENSATION (Det_5

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	Jan. 18, 2007	Apr. 30, 2015	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Feb. 28, 2015	May 31, 2014	Dec. 31, 2013
Number of shares available			6,901,360		6,901,360
Average share price (in dollars per share)			$ 3.73
Unrecognized pre-tax non-cash compensation expense to non-vested option			$ 9,652,000		$ 9,652,000
Period unrecognized pre-tax non-cash compensation expense to non-vested option			3 years
Number of shares vested			2,950,000
Minimum [Member]
Vesting period			2 years
Maximum [Member]
Vesting period			3 years
General And Administrative Expense [Member]
Non-cash compensation expense			$ 1,358,503	$ 770,862
Stock Incentive Plan [Member]
Plan expiration term	10 years
Number of shares authorized	2,500,000	5,100,000				4,600,000	4,250,000	3,500,000
Stock Incentive Plan 2015 [Member]
Number of shares authorized		5,000,000
Description of plan		Provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2017
Purchase of common shares				1,100,000
Stock Option Plan 2015 [Member]
Purchase of common shares			1,270,000		5,640,000
Average share price (in dollars per share)					$ 3.85
Fair value of common shares purchased					$ 5,970,000
Director [Member]
Unrecognized compensation expense			$ 111,196		$ 111,196
Weighted average period of unrecognized compensation expense			11 months 1 day

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	May 09, 2019	Mar. 31, 2019
Stock options granted		1,269,000
Subsequent Event [Member] | Stock Incentive Plan 2015 [Member]
Stock options granted	109,488
Options exercised, value	$ 56,400